Precision Biosciences (DTIL) Receivables - Net (2018 - 2025)
Precision Biosciences (DTIL) has disclosed Receivables - Net for 8 consecutive years, with $4000.0 as the latest value for Q3 2025.
- On a quarterly basis, Receivables - Net fell 97.87% to $4000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $4000.0, a 97.87% decrease, with the full-year FY2024 number at $229000.0, down 74.58% from a year prior.
- Receivables - Net was $4000.0 for Q3 2025 at Precision Biosciences, roughly flat from $4000.0 in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $50.5 million in Q2 2022 to a low of $4000.0 in Q1 2025.
- A 5-year average of $4.4 million and a median of $488000.0 in 2021 define the central range for Receivables - Net.
- Peak YoY movement for Receivables - Net: soared 10249.8% in 2022, then crashed 98.97% in 2025.
- Precision Biosciences' Receivables - Net stood at $488000.0 in 2021, then skyrocketed by 47.54% to $720000.0 in 2022, then increased by 25.14% to $901000.0 in 2023, then plummeted by 74.58% to $229000.0 in 2024, then plummeted by 98.25% to $4000.0 in 2025.
- Per Business Quant, the three most recent readings for DTIL's Receivables - Net are $4000.0 (Q3 2025), $4000.0 (Q1 2025), and $229000.0 (Q4 2024).